Ipamorelin

Research-grade Ipamorelin represents a benchmark in selective secretagogue peptide synthesis. Each batch is produced using SPPS and purified via preparative HPLC. Final identity and molecular weight are confirmed through ESI-MS. Laboratories examining receptor selectivity often compare Ipamorelin against other growth hormone-releasing peptides to isolate its distinct binding profile.

Ipamorelin research centers on its proposed role as a selective ghrelin receptor agonist, with investigators examining how it stimulates growth hormone release without the broader cortisol or prolactin elevation associated with less selective secretagogues. Its comparatively clean receptor profile makes it a useful candidate for dose-response titration studies and comparative pharmacological mapping.

Every batch of Ipamorelin is synthesized using Solid-Phase Peptide Synthesis (SPPS) and purified via preparative HPLC to eliminate truncated sequences and synthesis byproducts. Final identity confirmation is performed via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying exact molecular weight. Each lot ships with a Certificate of Analysis documenting purity exceeding 99%, giving researchers traceable, batch-specific verification before use in any laboratory protocol.

This product is strictly for research and laboratory use only. It is not approved by the FDA or any global regulatory body for human consumption, veterinary use, or therapeutic application. The purchaser assumes all responsibility for the proper handling, storage, and application of this compound. It must only be handled by qualified professionals in a controlled laboratory setting. By purchasing this product, you agree to abide by all local and international laws regarding the use of research chemicals.